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Next-of-Kin Involvement in Regulatory Investigations of
Adverse Events That Caused Patient Death: A Process
Evaluation (Part II: The Inspectors' Perspective)
Siri Wiig, PhD, MSc,* Lene Schibevaag, MSc,* Rannveig Tvete Zachrisen, MSc, RN,*
Einar Hannisdal, PhD, MD,† Janet E. Anderson, PhD, MSc,‡ and Cecilie Haraldseid-Driftland, PhD, RN*
Objective: The aim of the study was to explore regulatory inspectors' ex-
periences with a new method for next-of-kin involvement in investigation
of adverse events causing patient death. A resilient healthcare perspective
is used as the theoretical foundation.
Methods: The study design was a qualitative process evaluation of the
new involvement method in 2Norwegian counties. Next of kin, who had lost
a close family member in an adverse event, were invited to a 2-hour face-
to-face meetingwith the inspectors. Data collection involved 3 focus group
interviews with regulatory inspectors and observation (20 hours) of the
meetings (2017–2018). Datawere analyzed by a thematic content analysis.
Results: Next-of-kin involvement informed the investigations by addi-
tional and new information about the adverse events and by different ver-
sions of the investigators' earlier obtained information, such as time
sequences, what happened and how, and who were involved. Inspectors
considered next of kin as a key source of information that contributed to
improve the quality of the investigation. The downside was that the in-
volvement method increased work load and could challenge the principle
of equal treatment in regulatory practice.
Conclusions: Involvement of next of kin in regulatory investigation of
adverse events causing patient death contributes to a better understanding
of work as done in clinical practice and contributes to strengthen the learn-
ing potential in resilience.
Key Words: next of kin, regulatory inspections, adverse events, death
(J Patient Saf 2019;00: 00–00)
I n this article, we demonstrate the link between regulation andco-creation of resilience in healthcare. We explore how innova-
tion in regulatory investigation methods at the healthcare system
macro level can link regulatory inspectors with next of kin at the
micro level, in face-to-face meetings. When next of kin are given
opportunity to tell their version of the story about how a close rel-
ative died because of medical harm, they may contribute with in-
depth knowledge of work as done in healthcare, to the regulatory
body. Based on this knowledge and interaction between inspectors
and next of kin, we are able to study resilience mechanisms in the
interface between the regulator and next of kin and how adaptation
in regulatory practice takes place to improve processes and outcome.
User Involvement in Regulation and Follow-up
After Adverse Events Causing Death
A high number of patients are harmed every year in
healthcare,1–3 and they and their next of kin experience the pro-
cess after the event as difficult, including neglect, and cover-ups
by healthcare organizations.4 In Norway, a large proportion of
the most severe adverse events reported to the Norwegian Board
of Health Supervision relate to death due to medical harm.5,6 In
many of these cases, either the Norwegian Board of Health Super-
vision (regulatory body at the national level) or the County Gov-
ernor (regulatory body at the regional level) will initiate an
investigation to reveal whether healthcare services were provided
according to legislation and sound professional practice. The
usual approach to collecting information in these investigations
is by written information exchange between the service provider
(hospital or municipality), the individual healthcare professional,
and the regulatory body. There has been critique of the narrow
written information exchange and the limited involvement of pa-
tients, users, and family members in regulatory activities.6 There
is a growing international interest in involving patients and family
in disclosure and analysis of events at the service provider and reg-
ulatory level.5,7–9 Previous research has shown that there is often a
mismatch between the perspectives of patients and regulators on
healthcare quality and which areas of healthcare that regulators
should examine to improve care quality.10,11 Some studies from
the Netherlands describe experiences from using different patient
and family involvement methods at the regulatory level, such as
web-based surveys, interviewwith patients, and use of lay persons
in the investigation work, resulting in new types of information
used by the regulator.8 However, there is a gap in the literature
on involvement of the bereaved next of kin in regulatory activities
when patients have died in adverse events.12
Resilience and Regulation
Literature within resilient healthcare13,14 has recently shown
how next of kin are key in co-creation of resilience and play an im-
portant role in ensuring sound patient care. Resilient healthcare
can be defined as “a healthcare system's ability to adjust its func-
tioning before, during, or following changes and disturbances, so
that it can sustain required performance under both expected and
unexpected conditions.”15p.xxv Bergerød et al16 showed that next
of kin are important stakeholders in quality and safety in cancer
care. Their in-depth knowledge of the patient's history and their
observations of the patient over time and during care transitions
are key elements of their contribution to co-creation of resilience.
However, studies adopting a perspective combining resilient
healthcare perspectives and next of kin as co-creators of resilience
at the regulatory level are absent in the literature.17–19 Some
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high-profile severe adverse events in Norway have marked a
call for the development of methods for next-of-kin involve-
ment in regulatory investigation of adverse events causing pa-
tient death, to increase understanding of the complex causality,
and to take advantage of information from the next of kin.20,21
Next of kin may have been at the bedside and will have experi-
enced the adverse event from a different perspective than the in-
volved healthcare professionals.16,17 Therefore, they may have
potential valuable information for the regulatory bodies who in-
vestigate whether healthcare was provided according to the law.
There is also a need to know more about resilience mechanisms
at the regulatory level17–19 including how the regulators adapt
their practice to new information and how next of kin can contrib-
ute to supplement the inspectors' understanding of how clinical
work is done in practice when patients are harmed and die.
Regulatory Methods Innovation in Norway
There is a limited tradition for involving the next of kin in
macro level regulatory practice in Norway. As part of a response
to a heavy critique of this insufficient involvement practice, the
Norwegian Board of Health Supervision developed a user in-
volvement strategy and funded development projects to improve
involvement of next of kin in regulatory practice. One of these
projects was conducted by one county governor who oversees
healthcare services in 2 counties, approximately 25% of the total
Norwegian population.5 This county governor designed a new
user involvement method where next of kin from 50 families,
who had experienced the loss of a close family member in an adverse
event, were invited to a 2-hour face-to-face meeting with the regula-
tory inspectors (medical doctor and legal practitioner). The meeting
took place at the county governor's office as part of the regulatory in-
vestigation, to shed light on the event from the next of kin's perspec-
tive. Researchers from the University of Stavanger were involved to
conduct a process evaluation of the new regulatory method and
how it was experienced by the regulators and the next of kin.
Objective and Research Question
The objectives were to explore expectation and experiences
from the regulatory inspectors' perspective of the new involve-
ment method and to evaluate whether it contributed to new infor-
mation about the incident and whether it led to adaptations of the
regulatory investigation practice. The results will be discussed
using a resilient healthcare perspective.
The following research question guided the study:
1. How do regulatory inspectors expect and experience that next-
of-kin involvement in investigations of the most severe adverse
events influence the regulatory process?
METHODS
Design
The study was designed as a qualitative process evaluation.22 The
data collectionwas conducted during 11months (2017–2018) and in-
volved focus group interviews with regulatory inspectors, obser-
vation of the meetings, and interviews with the next of kin who
had participated.
Data Collection and Analysis
In this article, we focus on the perspective of the inspectors. A
total of 3 focus group interviewswere conducted in the early phase
of the project in September 2017 (3 informants) and then repeated
after 6 months (5 informants) and 10 months (4 informants). We
interviewed the same inspectors to map their expectations and
experiences over time. The inspectors were recruited by the regula-
tory project manager at the county governor office. The regulatory
project manager did not attend the focus group interview, to prevent
participants feeling inhibited about speaking freely. The interviews
were conducted according to an interview guide aiming to map
the expectations and experiences with the meeting (advantages/
disadvantages, change in regulatory practice, improvement sug-
gestions). Two researchers conducted the interviews. All inter-
views were tape recorded and transcribed.
In addition, we conducted observations in 8 meetings (20 hours)
where a total of 16 next of kin participated (Table 1 for information
about the observations). In each meeting, an inspection team of 1
doctor (the same inn all meetings) and 1 or 2 legal professionals
participated. The observation also included the premeetings held
by the inspection team and their discussion after the meeting.
All next of kin were asked by the regulatory project manager if
a researcher could observe the meeting, as part of an evaluation.
All families accepted. An observation guide was developed
and focused on how the meeting was conducted, language,
interaction, communication patterns, emotional reactions, and
power balance. During observation, field notes were taken.
The transcribed data material from the interviews and observa-
tions was analyzed according to a thematic content analysis.23 All
researchers read the total material and discussed the themes to
agree and refine the analysis. The themes were divided into posi-
tive experiences, negative experiences, and suggestions for im-
provement, as seen from the inspectors' point of view.
Ethical Approval
The study was approved by the Norwegian Centre for Re-
search Data (Reference Number 54865). All participants signed
informed consent.
RESULTS
The results are presented theme-wise hereinafter, and an over-
view with examples is provided in Table 2.
Positive Experiences
Next-of-kin Involvement Informs the Investigation
The results showed that meeting bereaved family members
face-to-face differed significantly from ordinary regulatory inves-
tigation that the inspectors were familiar with. Usual regulatory
practice is based on written information exchange between the in-
volved stakeholders. The observation showed that the next of kin
were given time to tell their side of the story to the inspectors,
without interruptions. The inspectors could, if needed, explain
the content of medical or juridical information in written documents,
such as patient records, letters, and statements sent to the next of kin
as part of the ongoing investigation. The need to explain the content
of the often large amount ofwritten information to the next of kinwas
frequently observed and mentioned by the inspectors in the inter-
views. Before each new meeting, the inspectors conducted a
premeeting where they went into the details in each case (e.g., med-
ical record, letters, complaints) and ensured that they were well pre-
pared and agreed on the agenda. The medical doctor (regulatory
project manager) chaired the meeting and the legal professional sup-
plemented and asked follow-up questions. They never rushed the
agenda and always took the time needed to talk to and listen, although
the meeting could last longer than the intended 2 hours.
The inspectors were able to gain additional and new informa-
tion about the adverse event causing the patient's death, and differ-
ent versions of earlier obtained information, such as time
sequences and how and what happened, and who were involved
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both in terms of healthcare professionals, but also different institu-
tions and services levels. The inspectors considered the meeting as
a method where they got detailed explanations of conditions
around the patient, which were often not included in the medical
records or in documents and statements sent from the healthcare
professionals or the institutions. The observation showed that the
next of kin could elaborate on their experiences of the event,
causal chain, and give details about who had been involved at dif-
ferent stages and time of the patient journey, which the inspectors
found to be crucial information for their investigation. The meet-
ing often resulted in additional information gathering from the in-
volved service providers and from new services providers that
next of kin identified for the inspectors in the meeting.
The inspectors considered next of kin as a key source of infor-
mation that contributed to improve the quality of the investigation.
They considered the method as being adaptive and flexible in
what kind of questions that could be asked to the different next
of kin. Inspectors had to be sensitive to each next of kin and their
emotional state in the meeting. However, usually, inspectors were
surprised of how well next of kin handled the meeting and the dif-
ficult situation of going into details about the event when the pa-
tient died. The inspectors experienced that they could adapt
follow-up questions to be more targeted to their needs, to inform
the investigation. In particular, they argued that the meeting is
helpful and works well when cases are complex and involve mul-
tiple stakeholders, because information provided by the next of
kin contributed to a more holistic picture of the adverse event
and the involved stakeholders.
Involvement is Emotionally Challenging but in
Accordance With Political Expectation
The inspectors experienced the meetings as a way of acting
more in accordance with political expectations for user involve-
ment in healthcare—also at the regulatory level. Some argued that
the regulatory body should be more open to the users in general
than current practice, whereas others were more skeptical because
it may raise too high expectations for involvement in all cases. The
inspectors experienced the method as a safe space for the next of
kin, who often had been in heavy conflicts with the service pro-
viders. Inspectors could read about frustration, anger, and rage
of not being heard, in the medical records and the complaints. In
addition, someone then took the time to listen and explain which
had a resemblance to a therapeutic effect for the next of kin, al-
though that was not the purpose of the meeting. The grief and
the emotional aspects were handled at the end of every observed
meeting. The inspectors asked how the next of kin felt and
whether they needed professional follow-up. The meeting was
also an emotionally challenging situation for the inspectors them-
selves, because they were sometimes worried about attending be-
forehand and continued to think about it after the meeting.
However, they argued that it was a positive experience to be a sup-
port, help, and being able to clarify misunderstandings or ques-
tions from next of kin in the meeting. The inspection team
conducted a short debriefing session after the meeting. A lecture
from a psychologist about emotional reactions and response was
the only training session before the project start up. The observa-
tions showed a strong collegial support to deal with emotional re-
actions among the inspectors.
Negative Experiences
Involvement Increases Work Load and Challenges the
Principle of Equal Treatment
The results were consistent over time, and although the inspec-
tors expected that some cases would take less time, their experi-
ence was that the meetings added more work. Their organization
had not supported them with additional resources, except from
the regulatory project manager who was partly funded and
exempted from other work tasks. Therefore, the inspectors argued
that although the investigation quality was improved by next-of-
kin involvement, it cannot be justified as a regular practice, unless
additional resources are allocated to the office.
According to the inspectors, there was a need to develop
criteria for judging when a meetingwould be helpful. The meeting
has much to offer in the most complex adverse events, but at the
same time, an individual assessment of utility for a meeting in
each case would challenge the principle for equal treatment in
TABLE 1. Observation of Meeting and Short Description of Case
Observation of
Meeting Number
Next of kin Present at
Meeting and Relation
to the Patient Short Case Description
No. Inspectors
Present at Meeting
1 1 (wife) Man died of cerebral hemorrhage, he had a
history of evolving symptoms, and multiple
stakeholders were involved.
2
2 2 (mother and father) Young woman died after comprehensive
cancer surgery – questioning the diagnostic delays.
2
3 3 (mother, brother, sister) Man died because of heart attack after delayed
response from emergency service central.
2
4 2 (wife and daughter) Man found dead in a parking lot. General
practitioner did not suspect heart disease.
2
5 2 (mother and father) Baby died before birth – questioning follow-up 2
6 2 (mother and big brother) Young man committed suicide when
hospitalized in psychiatric hospital
(under commitment).
2
7 1 (son) Woman using anticoagulant was sent home after
consultation and died after a fall of cerebral
hemorrhage consultation in emergency department.
2
8 3 (wife, son, daughter) Man died of multiorgan failure after perforation
of coronary artery during cardiac surgery.
2
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regulation. The inspectors, therefore, argued that it is easier to re-
fuse a request for face-to-face meetings with the argument that the
regulatory practice applies written information exchange only.
They also worried that the most resourceful next of kin (high ed-
ucation, strong family relations, and salary) would accept the
meeting invitation, whereas other groups would tend to decline,
as experienced in some of their cases.
Suggestions for Further Methods Improvement
Improve Selection Criteria and Allow Differentiation
Based on the experiences of the meeting, the inspectors argued
that the method could be further improved by allowing for a better
differentiation of cases of patient deaths, implying that more flex-
ible but high threshold selection criteria were needed. Some expe-
rienced that the meeting did not provide so much additional
information in the suicide cases and argued that resources should
be prioritized to other areas. In addition, they argued that the in-
spectors should not indicate anything about the conclusion of
the case during meetings. Finally, the inspectors suggested to in-
clude a medical doctor trained with a primary care background.
Currently, a doctor with oncology and hospital background chaired
all meetings, but the regulatory follow-up process would involve a
doctor (inspector) working with primary care as work area but
who was not part of the project.
DISCUSSION
In this article, we have seen how regulatory methods innovation
is developed and tested as a response to a public pressure for user
involvement at all levels in healthcare (e.g., Adams et al8). Our
study focused on how next-of-kin involvement contributes to im-
prove regulatory investigations of adverse events causing patient
death, as seen from the regulatory inspectors' perspective. The main
finding was that the inspectors experienced next-of-kin involve-
ment as method that informed and improved quality of the investi-
gations by adding new and important information. The downsides
were added workload and lack of resources to follow up the new in-
formation and stakeholders identified in the meeting. In the follow-
ing, we discuss the findings in a resilient healthcare perspective.
There are several lessons learned from our study in a resilient
healthcare perspective.13,15,24 First, most studies of resilient
healthcare take place at the micro level.17,25–27 However, studies
of empirical practices or innovative methods that bridge the micro
and the macro level and integrate the patient or next of kin are re-
quired to ensure that the perspective of resilient healthcare is
TABLE 2. Overview of Themes
Theme Subtheme Quote
Positive experiences Next-of-kin involvement
informs the investigation
“I think we have gained much more relevant information in the meetings, than
I anticipated before we started… The next of kin has been very structured, I think.
We get a lot of additional information when we talk with them, and can
ask follow-up questions. We get the entire time line in a new way. It is about
what happened, when, what kind of symptoms, and you can ask about more
details…. For example the patient history, the procedures, and one patient
had been to several other service providers, than the doctors said, and
we had to request additional information. In that case, our investigation
was expanded to cover additional service providers, after the meeting.
The next of kin did not include this information in the original complaint,
because they did not think it was important, but then we could ask about it
[in the meeting]” (Int. 1).
“We use more time in these cases. I have only been involved in one case, but we
got an entire new understanding of the event, and expanded the investigation to
additional service providers, and it became much more comprehensive. I think it
is very good, because I want us to be thorough in our approach and not just close
the case. I think it is a good project, and it contributes to improve our investigation
quality, but not efficiency, like it was anticipated when we started the project.”
(Int. 1).
Involvement is emotionally
challenging, but in accordance
with political expectation
“In the first meeting I attended, a couple had lost their 1.5-year-old daughter.
It was horrible. And also the meeting last week, when I sat there and tried not to cry….
I have been in the same situation with my child at the same hospital, and I really
worried about the meeting beforehand and I didn't have any training. I'm just
a legal professional.” (Int. 2).
“All the next of kin have told us it felt good for them to meet us, and that is a very
positive experience for me.” (Int.1)
Negative
experiences
Involvement increases work load
and challenges the principle
of equal treatment
“If you ask one of us, do we want this (meeting), we will think that we have a
certain amount of hours available, because we have lots of work, and then we think
what will we have to sacrifice? It perhaps improves investigation quality in
some cases, but at the same time we think of those who will not get a response
from us in their case…” (Int. 3)
“When we start the case we send the invitation and I have experienced several
rejects…” (Int. 1)
“I am worried, that it is only the most resourceful next of kin who accept the
invitation…” (Int.1)
Suggestions for
improvement
Improve selection criteria
and allow differentiation
“I have thought several times that it didn't really inform the legal investigation.
I think it is because in the suicide cases it is not so much medical details as in acute
hospitals, so it is quite different, so speaking from a resource perspective I don't think
the suicide cases should be prioritized.” (Int.3)
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theoretically and practically developed.14,17,19 Resilient healthcare
is a multilevel phenomenon,17,18,25,28 and as seen in our study, it
needs to expand beyond a micro level approach in the healthcare
system. Our study showed that a simple method for next-of-kin in-
volvement in regulatory investigation of fatal adverse events fostered
an increased information richness for the regulatory inspectors that
exceeded their expectations. To promote the learning potential in re-
silience,15 information about what actually happened (work as done)
is key during regulatory investigations. The stories from next of kin
complemented the inspectors' picture and often differed from the
written information collected about the adverse event before the
meeting (work as imagined). We argue that this involvement
method also has the potential to provide additional information
in investigation of nonfatal adverse events, but then, the patient
should also be involved. By increasing the information richness
in investigations, we argue that the next-of-kin involvement con-
tributes to co-creating resilience at the regulatory level. Our study
corroborates Bergerød et al's16 study, showing that next-of-kin in-
volvement is a “stakeholder potential,” which strengthens or sup-
ports the 4 resilience potentials (anticipation, monitoring,
responding, and learning). In the regulatory investigations of ad-
verse events, the learning potential is most relevant, and the
next-of-kin involvement strengthened the learning information
that inspectors use in their assessment and final report, which is
fed back to the services. Adverse events (fatal and nonfatal) are
examples of system failure and often cause distrust. Involvement,
listening, and learning from the next of kin are therefore mecha-
nisms that bridge system levels in resilience and may also contrib-
ute to restoration of trust in the healthcare system.
Second, the meeting is supplementing the regulatory tool kit by
being more responsive to the views of next of kin than current
practice.29,30 The meeting could be adapted to different types of
contexts (hospital, primary care, psychiatry) and identified prob-
lems that were not only associated with clinical standards.11 Next
of kin identified, for example, that additional stakeholders were in-
volved or that the problem had a longer time line or different se-
quence. The dialog contributed to a more holistic conceptualization
of the event. Previous studies31,32 have suggested that regulatory bod-
ies should take more advantage of people-to-people approaches to
knowledge management33 (e.g., meeting, face-to-face dialog, inter-
views), instead of relying solely on people-to-documents approaches
(letters, medical records, databases) to foster better learning pro-
cesses. Such meetings contribute to bridging a gap in regulatory
methods and should be further tested in a larger scale. However,
to succeed, further development of adaptive selection criteria is
needed in addition to leadership priority and funding.
Third, we argue that this innovation in regulatory practice illus-
trates that regulation and resilience are two concepts that can be
linked and should not only be conceptualized as counterparts. It
also shows that resilience mechanisms exist at the regulatory level
when the regulator adapts to external pressure, improves their own
methods by testing a new involvement arena, and starts seeing
next of kin as an important information source improving investi-
gation quality.18 We recommend further research to explore both
resilience mechanisms within the regulatory body and in the inter-
face between regulators, regulated organizations, and the public
(next of kin, patients, stakeholders). Flexibility, adaptations, and
responsiveness are mechanisms of interest for both regulation
and resilience to improve service performance18 and should be
approached in a multilevel perspective to build new knowledge.17
Limitations
The sample size is a limitation. However, we interviewed all in-
spectors involved in the project and our observations supplement
the perspective of how the method contributed to inform the
investigation.34 We did not conduct a pilot test; however, we
interviewed the same inspectors over time, which gave us opportu-
nity tomake adjustments and ask follow-up questions. The next of
kin' experience is not covered in this article but will be in an addi-
tional publication,35 which is necessary to evaluate the method.
CONCLUSIONS AND RECOMMENDATIONS
There has been a call for methods development to improve user
involvement in regulatory practice. Our study indicates that there
is a need for face-to-face meeting opportunities between the next
of kin and regulatory inspectors in selected cases, such as part of
the follow-up of the most complex adverse events. There is a need
to refine the selection criteria for such meetings, and further re-
search should explore the extent of cases that changed direction
and possible conclusion based on the next-of-kin involvement in
the investigations of adverse events causing death. Face-to-face
communication enables richer information and supplements current
methods of data collection and user involvement in regulatory prac-
tice. Involvement of next of kin in regulatory investigation contrib-
utes to a better understanding of work as done in clinical practice
and contributes to strengthen the learning potential in resilience.
We recommend a potential further implementation of involve-
ment methods in regulatory investigations of both fatal and nonfa-
tal adverse events to have sound leadership anchoring, because
our study showed that new involvement methods require proper
resources, training, and time to be meaningful to both inspectors
and next of kin.
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